The 'Ozempic soup' recipe trend: What TikTok gets wrong

What did @extensionesmaar1 actually say?

Honestly, the transcript here is nearly incoherent. The audio captured what appears to be a garbled or mistranscribed voiceover, leaving us with phrases like "I hope that my journey between being Formation and being completely resilient" and "the future is going to happen so I couldn't stop." None of that maps to any coherent health claim.

What we can work with is the caption and hashtags. The creator is promoting a recipe they're calling "sopita Ozempic" (little Ozempic soup), promising viewers it will help them "bajar muy rápido" (lose weight very fast). The hashtag #sopitaozemic makes the implied comparison explicit: this soup is supposed to mimic or replicate what Ozempic, the brand name for semaglutide, does in the body. That is a specific and verifiable claim worth taking seriously, even if the spoken content couldn't be transcribed reliably.

Does the science back this up?

No. There is no food, soup, or recipe that replicates the pharmacological mechanism of semaglutide. Full stop.

Semaglutide works by binding to GLP-1 receptors, slowing gastric emptying, suppressing appetite signaling in the hypothalamus, and stimulating insulin secretion in a glucose-dependent manner. These effects come from a synthetic peptide molecule that survives first-pass metabolism specifically because it's been engineered with albumin-binding fatty acid chains. You cannot get that from a bowl of soup.

The "Ozempic soup" trend, which spread widely on social media in 2023 and 2024, is typically a low-calorie vegetable broth recipe. Mendes et al. (2023, Nutrients) and other satiety research confirm that high-fiber, low-energy-density foods can support modest short-term fullness. But "supports satiety" is not the same as "mimics a GLP-1 receptor agonist." The weight loss seen with semaglutide in the STEP trials (Wilding et al., 2021, New England Journal of Medicine) averaged 14.9% body weight over 68 weeks at the 2.4mg dose. No soup produces that outcome.

What did they get wrong (or right)?

The misleading part is the framing, not necessarily the soup itself. A low-calorie vegetable soup is not a bad food choice. Dietary patterns emphasizing vegetables, fiber, and reduced caloric density are genuinely associated with weight management. Rolls et al. (2004, Obesity Research) showed that soup consumed before a meal reduced total caloric intake by about 20% in a controlled study. That is a real, modest effect.

What is wrong is calling this "sopita Ozempic" and implying it produces rapid weight loss the way a GLP-1 medication does. That framing sets false expectations. People who actually need treatment for obesity or type 2 diabetes may delay seeking medical care because they believe a recipe will do the same job. That delay has real health consequences.

The phrase "bajas muy rápido" (you lose weight very fast) is also not supported by any evidence for a soup recipe. Rapid weight loss from diet alone typically requires severe caloric restriction, which carries its own risks including muscle loss, gallstone formation, and nutrient deficiency (Tsai and Wadden, 2006, Annals of Internal Medicine).

What should you actually know?

GLP-1 receptor agonists like semaglutide and tirzepatide are prescription medications regulated by the FDA. They require a clinical evaluation, ongoing monitoring, and a prescription from a licensed provider. They are not interchangeable with food, supplements, or recipes, regardless of what a TikTok caption implies.

If you are looking for dietary changes that genuinely support weight management, the evidence points toward high-protein meals, fiber-rich vegetables, and reduced ultra-processed food intake as components of a sustainable approach. Jensen et al. (2014, Circulation) from the American Heart Association and American College of Cardiology guidelines on obesity management outline what dietary interventions can actually accomplish without medication.

If your weight is affecting your health and you want to explore whether a GLP-1 medication might be appropriate for you, that conversation starts with a licensed clinician, not a soup recipe. FormBlends connects patients with regulated telehealth providers who can do that evaluation properly.